Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphoric acid catalyzed method for high-purity tetrahydroacridines. Reduces steps and improves enantioselectivity for pharma intermediates.
Novel axial chiral indole-furan catalyst patent CN117720537B enables mild asymmetric synthesis. Offers high enantioselectivity and cost-effective manufacturing for reliable pharma intermediate supply chains.
Novel chiral phosphoric acid catalysis for indolocyclopentanes. High yield, scalable process for anticancer drug development. Reliable supply chain partner.
Advanced synthesis method for Oseltamivir phosphate isomer impurity ensuring quality control. Reliable supplier for pharmaceutical intermediates with cost reduction.
Patent CN113735867B reveals high-yield chiral synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Patent CN115785122A details a novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines with high cytotoxicity, offering a scalable route for reliable pharmaceutical intermediate suppliers.
Patent CN110903231B details a mild TfOH-catalyzed route to 2-cyanopyrroles. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN116768904B reveals high-yield chiral synthesis for antitumor intermediates, offering significant cost reduction and enhanced supply reliability for global pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN120923511A details novel synthesis for vinyl indolo cyclic compounds with high enantioselectivity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid catalysis. Offers high ee, mild conditions, and scalable production for pharmaceutical applications.
Novel chiral phosphoric acid catalysis for high-purity anticancer intermediates. Cost-effective scale-up and reliable supply chain solutions for global pharmaceutical manufacturing partners.
Novel bismuth-catalyzed route offers high yields and recyclability for asymmetric triarylmethane derivatives, reducing costs in pharmaceutical intermediate manufacturing.
Patent CN113735867B reveals mild synthesis for antitumor intermediates. Offers high yield and enantioselectivity for cost-effective supply chain solutions.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Patent CN118878452B reveals a mild catalytic route for anti-tumor intermediates. This report analyzes supply chain stability and cost reduction in pharma manufacturing.
Novel synthesis method offers mild conditions and high yield for pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global partners seeking advanced antitumor solutions
Novel synthesis method for chiral indolo compounds with high enantioselectivity. Cost-effective manufacturing for pharmaceutical applications ensuring supply chain reliability.
Patent CN120923511A details mild synthesis of chiral vinyl indolo compounds. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110467555A reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Enables cost reduction and supply chain reliability for global buyers.